The role of antiviral and immunoglobulin therapy in the prevention of Epstein–Barr virus infection and post‐transplant lymphoproliferative disease following solid organ transplantation
Authors:
- 1 June 2001
- journal article
- review article
- Published by Wiley in Transplant Infectious Disease
- Vol. 3 (2) , 97-103
Abstract
The recognition of the importance of Epstein–Barr virus (EBV) infection, including EBV‐associated post‐transplant lymphoproliferative disease (PTLD), has led to a new focus on the prevention of this problem. This paper reviews the scientific rationale behind, and clinical experience with, the use of chemoprophylaxis (using acyclovir or ganciclovir) and immunoprophylaxis (using intravenous immunoglobulin) in the prevention of EBV/PTLD. While some centers have already introduced the use of one or both of these agents as standard prophylaxis against the development of this complication, published data in support of these protocols are currently lacking. Well designed clinical trials are necessary to evaluate the potential role of both antiviral and immunoglobulin agents in the prevention of EBV/PTLD in organ transplant recipients.Keywords
This publication has 28 references indexed in Scilit:
- Epstein‐Barr Virus Gene Expression in the Peripheral Blood of Transplant Recipients with Persistent Circulating Virus LoadsThe Journal of Infectious Diseases, 2000
- EPSTEIN-BARR VIRUS-INDUCED POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERSTransplantation, 1999
- The antiviral prophylaxis of post-transplant lymphoproliferative disorderSpringer Seminars in Immunopathology, 1998
- Role of donor versus recipient type Epstein-Barr virus in post-transplant lymphoproliferative disordersSpringer Seminars in Immunopathology, 1998
- PREVENTION AND PREEMPTIVE THERAPY OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE IN PEDIATRIC LIVER RECIPIENTS1Transplantation, 1998
- POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE IN PEDIATRIC LIVER TRANSPLANTATIONTransplantation, 1996
- EPSTEIN-BARR VIRUS DNA IN PERIPHERAL BLOOD LEUKOCYTES OF PATIENTS WITH POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASETransplantation, 1995
- Early identification of Epstein‐Barr virus‐associated post‐transplantation lymphoproliferative diseaseBritish Journal of Haematology, 1995
- Preemptive Therapy in Immunocompromised HostsNew England Journal of Medicine, 1991
- Epstein–Barr Virus-Induced B-Cell Lymphoma after Renal TransplantationNew England Journal of Medicine, 1982